<p>拥有大量资金的投资者对 <strong>Abivax</strong> (NASDAQ: ABVX) 持悲观态度。</p>
<p>而散户交易者应该知道这一点。</p>
<p>我们今天注意到这一点，因为这些头寸出现在我们在 Benzinga 跟踪的公开可用期权历史中。</p>
<p>我们不知道这些是机构还是仅仅是富有的个人。但当 ABVX 发生如此重大的事情时，通常意味着有人知道即将发生什么。</p>
<p>今天，Benzinga 的期权扫描仪发现了 12 笔 <strong>Abivax</strong> 的期权交易。</p>
<p>这并不正常。</p>
<p>这些大资金交易者的整体情绪在 41% 看涨和 50% 看跌之间分裂。</p>
<p>在我们发现的所有期权中，有 1 笔看跌期权，总金额为 $31,360，和 11 笔看涨期权，总金额为 $605,529。</p>
<h3>预期价格变动</h3>
<p>分析这些合约的成交量和未平仓合约，似乎大玩家在过去一个季度内关注的价格区间为 $90.0 到 $175.0。</p>
<h3>成交量与未平仓合约趋势</h3>
<p>查看成交量和未平仓合约是交易期权时的一个强有力的举措。这些数据可以帮助你跟踪 Abivax 在特定行权价的期权流动性和兴趣。下面，我们可以观察到在过去 30 天内，所有 Abivax 的鲸鱼交易在 $90.0 到 $175.0 的行权价范围内的成交量和未平仓合约的演变。</p>
<h3>Abivax 30 天期权成交量与兴趣快照</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1768413676_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="期权看涨图表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1768413676_0.png"/></p>
<h3>发现的最大期权：</h3>
<table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th align="right"><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ABVX</td>
<td>看涨</td>
<td>扫描</td>
<td>看跌</td>
<td>01/16/26</td>
<td>$5.6</td>
<td>$5.5</td>
<td>$5.5</td>
<td>$125.00</td>
<td>$147.9K</td>
<td>533</td>
<td align="right">292</td>
</tr>
<tr>
<td>ABVX</td>
<td>看涨</td>
<td>扫描</td>
<td>看涨</td>
<td>02/20/26</td>
<td>$17.0</td>
<td>$13.5</td>
<td>$15.0</td>
<td>$130.00</td>
<td>$108.0K</td>
<td>465</td>
<td align="right">100</td>
</tr>
<tr>
<td>ABVX</td>
<td>看涨</td>
<td>交易</td>
<td>看跌</td>
<td>02/20/26</td>
<td>$11.0</td>
<td>$10.0</td>
<td>$10.0</td>
<td>$150.00</td>
<td>$88.0K</td>
<td>1.9K</td>
<td align="right">216</td>
</tr>
<tr>
<td>ABVX</td>
<td>看涨</td>
<td>交易</td>
<td>看跌</td>
<td>03/20/26</td>
<td>$28.9</td>
<td>$25.5</td>
<td>$26.63</td>
<td>$110.00</td>
<td>$39.9K</td>
<td>10</td>
<td align="right">15</td>
</tr>
<tr>
<td>ABVX</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>01/16/26</td>
<td>$14.9</td>
<td>$13.4</td>
<td>$14.9</td>
<td>$110.00</td>
<td>$37.2K</td>
<td>1.1K</td>
<td align="right">173</td>
</tr>
</tbody>
</table>
<h3>关于 Abivax</h3>
<p>Abivax SA 是一家总部位于法国的临床阶段生物技术公司，专注于开发利用身体自然调节机制的治疗方法，以稳定慢性炎症性疾病患者的免疫反应。该公司正在评估其药物候选者 obefazimod，在 3 期临床试验中用于治疗中度至重度活动性溃疡性结肠炎的成年人。其初步关注的是炎症性肠病，这是一种涉及胃肠道炎症的慢性疾病，其中两种常见形式为 UC 和 CD。</p>
<p>鉴于 Abivax 最近的期权历史，现在适合关注该公司本身。我们旨在探讨其当前表现。</p>
<h3>Abivax 的当前状况</h3>
<ul>
<li>目前交易量为 1,013,271，ABVX 的价格上涨了 1.32%，现为 $121.22。</li>
<li>RSI 指标显示该股票可能接近超买状态。</li>
<li>预计收益发布将在 68 天后。</li>
</ul>
<h3>专家对 Abivax 的看法</h3>
<p>在过去 30 天内，共有 3 位专业分析师对该股票发表了看法，设定的平均目标价为 $142.0。</p>
<ul>
<li>一位来自 Citizens 的分析师维持对 Abivax 的市场表现优于大盘评级，目标价为 $131。</li>
<li>一位来自 BTIG 的分析师继续对 Abivax 维持买入评级，目标价为 $150。</li>
<li>一位来自摩根士丹利的分析师决定维持对 Abivax 的增持评级，目前目标价为 $145。</li>
</ul>
<p>交易期权涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略性交易调整、利用各种指标以及关注市场动态来降低这些风险。</p>

ABVX

<p>投资者对 Abivax (NASDAQ:ABVX) 持悲观态度，50% 的大额交易者表现出看跌情绪。最近的期权活动显示出 12 笔交易，其中包括 1 笔价值 31,360 美元的看跌期权和 11 笔总计 605,529 美元的看涨期权。Abivax 的预期价格区间在 90.0 美元到 175.0 美元之间。目前，ABVX 的交易价格为 121.22 美元，上涨 1.32%。分析师设定的平均目标价为 142.0 美元，评级范围从市场跑赢到买入，尽管期权情绪悲观，但仍显示出增长潜力</p>

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Abivax</strong> (NASDAQ: ABVX).</p>
<div class="lb-trans"><p>拥有大量资金的投资者对 <strong>Abivax</strong> (NASDAQ: ABVX) 持悲观态度。</p>
</div><p>And retail traders should know.</p>
<div class="lb-trans"><p>而散户交易者应该知道这一点。</p>
</div><p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<div class="lb-trans"><p>我们今天注意到这一点，因为这些头寸出现在我们在 Benzinga 跟踪的公开可用期权历史中。</p>
</div><p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ABVX, it often means somebody knows something is about to happen.</p>
<div class="lb-trans"><p>我们不知道这些是机构还是仅仅是富有的个人。但当 ABVX 发生如此重大的事情时，通常意味着有人知道即将发生什么。</p>
</div><p>Today, Benzinga's options scanner spotted 12 options trades for <strong>Abivax</strong>.</p>
<div class="lb-trans"><p>今天，Benzinga 的期权扫描仪发现了 12 笔 <strong>Abivax</strong> 的期权交易。</p>
</div><p>This isn't normal.</p>
<div class="lb-trans"><p>这并不正常。</p>
</div><p>The overall sentiment of these big-money traders is split between 41% bullish and 50%, bearish.</p>
<div class="lb-trans"><p>这些大资金交易者的整体情绪在 41% 看涨和 50% 看跌之间分裂。</p>
</div><p>Out of all of the options we uncovered, there was 1 put, for a total amount of $31,360, and 11, calls, for a total amount of $605,529.</p>
<div class="lb-trans"><p>在我们发现的所有期权中，有 1 笔看跌期权，总金额为 $31,360，和 11 笔看涨期权，总金额为 $605,529。</p>
</div><h3>Expected Price Movements</h3>
<div class="lb-trans"><h3>预期价格变动</h3>
</div><p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $90.0 to $175.0 for Abivax during the past quarter.</p>
<div class="lb-trans"><p>分析这些合约的成交量和未平仓合约，似乎大玩家在过去一个季度内关注的价格区间为 $90.0 到 $175.0。</p>
</div><h3>Volume &amp; Open Interest Trends</h3>
<div class="lb-trans"><h3>成交量与未平仓合约趋势</h3>
</div><p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Abivax's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Abivax's whale trades within a strike price range from $90.0 to $175.0 in the last 30 days.</p>
<div class="lb-trans"><p>查看成交量和未平仓合约是交易期权时的一个强有力的举措。这些数据可以帮助你跟踪 Abivax 在特定行权价的期权流动性和兴趣。下面，我们可以观察到在过去 30 天内，所有 Abivax 的鲸鱼交易在 $90.0 到 $175.0 的行权价范围内的成交量和未平仓合约的演变。</p>
</div><h3>Abivax 30-Day Option Volume &amp; Interest Snapshot</h3>
<div class="lb-trans"><h3>Abivax 30 天期权成交量与兴趣快照</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1768413676_0.png" alt="Options Call Chart" original-src="https://www.benzinga.com/files/images/story/2026/1768413676_0.png"/></p>
<h3>Biggest Options Spotted:</h3>
<div class="lb-trans"><h3>发现的最大期权：</h3>
</div><table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ABVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$5.6</td>
<td>$5.5</td>
<td>$5.5</td>
<td>$125.00</td>
<td>$147.9K</td>
<td>533</td>
<td align="right">292</td>
</tr>
<tr>
<td>ABVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/20/26</td>
<td>$17.0</td>
<td>$13.5</td>
<td>$15.0</td>
<td>$130.00</td>
<td>$108.0K</td>
<td>465</td>
<td align="right">100</td>
</tr>
<tr>
<td>ABVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/20/26</td>
<td>$11.0</td>
<td>$10.0</td>
<td>$10.0</td>
<td>$150.00</td>
<td>$88.0K</td>
<td>1.9K</td>
<td align="right">216</td>
</tr>
<tr>
<td>ABVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$28.9</td>
<td>$25.5</td>
<td>$26.63</td>
<td>$110.00</td>
<td>$39.9K</td>
<td>10</td>
<td align="right">15</td>
</tr>
<tr>
<td>ABVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$14.9</td>
<td>$13.4</td>
<td>$14.9</td>
<td>$110.00</td>
<td>$37.2K</td>
<td>1.1K</td>
<td align="right">173</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th align="right"><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ABVX</td>
<td>看涨</td>
<td>扫描</td>
<td>看跌</td>
<td>01/16/26</td>
<td>$5.6</td>
<td>$5.5</td>
<td>$5.5</td>
<td>$125.00</td>
<td>$147.9K</td>
<td>533</td>
<td align="right">292</td>
</tr>
<tr>
<td>ABVX</td>
<td>看涨</td>
<td>扫描</td>
<td>看涨</td>
<td>02/20/26</td>
<td>$17.0</td>
<td>$13.5</td>
<td>$15.0</td>
<td>$130.00</td>
<td>$108.0K</td>
<td>465</td>
<td align="right">100</td>
</tr>
<tr>
<td>ABVX</td>
<td>看涨</td>
<td>交易</td>
<td>看跌</td>
<td>02/20/26</td>
<td>$11.0</td>
<td>$10.0</td>
<td>$10.0</td>
<td>$150.00</td>
<td>$88.0K</td>
<td>1.9K</td>
<td align="right">216</td>
</tr>
<tr>
<td>ABVX</td>
<td>看涨</td>
<td>交易</td>
<td>看跌</td>
<td>03/20/26</td>
<td>$28.9</td>
<td>$25.5</td>
<td>$26.63</td>
<td>$110.00</td>
<td>$39.9K</td>
<td>10</td>
<td align="right">15</td>
</tr>
<tr>
<td>ABVX</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>01/16/26</td>
<td>$14.9</td>
<td>$13.4</td>
<td>$14.9</td>
<td>$110.00</td>
<td>$37.2K</td>
<td>1.1K</td>
<td align="right">173</td>
</tr>
</tbody>
</table>
</div><h3>About Abivax</h3>
<div class="lb-trans"><h3>关于 Abivax</h3>
</div><p>Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.</p>
<div class="lb-trans"><p>Abivax SA 是一家总部位于法国的临床阶段生物技术公司，专注于开发利用身体自然调节机制的治疗方法，以稳定慢性炎症性疾病患者的免疫反应。该公司正在评估其药物候选者 obefazimod，在 3 期临床试验中用于治疗中度至重度活动性溃疡性结肠炎的成年人。其初步关注的是炎症性肠病，这是一种涉及胃肠道炎症的慢性疾病，其中两种常见形式为 UC 和 CD。</p>
</div><p>In light of the recent options history for Abivax, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<div class="lb-trans"><p>鉴于 Abivax 最近的期权历史，现在适合关注该公司本身。我们旨在探讨其当前表现。</p>
</div><h3>Current Position of Abivax</h3>
<div class="lb-trans"><h3>Abivax 的当前状况</h3>
</div><ul>
<li>Currently trading with a volume of 1,013,271, the ABVX's price is up by 1.32%, now at $121.22.</li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 68 days.</li>
</ul>
<div class="lb-trans"><ul>
<li>目前交易量为 1,013,271，ABVX 的价格上涨了 1.32%，现为 $121.22。</li>
<li>RSI 指标显示该股票可能接近超买状态。</li>
<li>预计收益发布将在 68 天后。</li>
</ul>
</div><h3>Expert Opinions on Abivax</h3>
<div class="lb-trans"><h3>专家对 Abivax 的看法</h3>
</div><p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $142.0.</p>
<div class="lb-trans"><p>在过去 30 天内，共有 3 位专业分析师对该股票发表了看法，设定的平均目标价为 $142.0。</p>
</div><ul>
<li>Maintaining their stance, an analyst from Citizens continues to hold a Market Outperform rating for Abivax, targeting a price of $131.</li>
<li>An analyst from BTIG persists with their Buy rating on Abivax, maintaining a target price of $150.</li>
<li>An analyst from Morgan Stanley has decided to maintain their Overweight rating on Abivax, which currently sits at a price target of $145.</li>
</ul>
<div class="lb-trans"><ul>
<li>一位来自 Citizens 的分析师维持对 Abivax 的市场表现优于大盘评级，目标价为 $131。</li>
<li>一位来自 BTIG 的分析师继续对 Abivax 维持买入评级，目标价为 $150。</li>
<li>一位来自摩根士丹利的分析师决定维持对 Abivax 的增持评级，目前目标价为 $145。</li>
</ul>
</div><p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics.</p>
<div class="lb-trans"><p>交易期权涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略性交易调整、利用各种指标以及关注市场动态来降低这些风险。</p>
</div>

Abivax 的选择：探讨大资金的想法